| 000 | 01701 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514005919.0 | ||
| 264 | 0 | _c20020206 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0036-5548 | ||
| 024 | 7 |
_a10.1080/00365540110026638 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPereiró, I | |
| 245 | 0 | 0 |
_aEpidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine. _h[electronic resource] |
| 260 |
_bScandinavian journal of infectious diseases _c2001 |
||
| 300 |
_a581-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Distribution |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Programs |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aNeisseria meningitidis _xisolation & purification |
| 650 | 0 | 4 |
_aPolysaccharides, Bacterial _xtherapeutic use |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aProgram Evaluation |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeasons |
| 650 | 0 | 4 |
_aSpain _xepidemiology |
| 700 | 1 | _aDíez-Domingo, J | |
| 700 | 1 | _aMorant, A | |
| 700 | 1 | _aGimeno, C | |
| 700 | 1 | _aLerma, M | |
| 700 | 1 | _aSan-Martín, M | |
| 700 | 1 | _aGonzález, A | |
| 773 | 0 |
_tScandinavian journal of infectious diseases _gvol. 33 _gno. 8 _gp. 581-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/00365540110026638 _zAvailable from publisher's website |
| 999 |
_c11449547 _d11449547 |
||